Bridging Science for Better Health

West Coast Clinical Trials has a professional staff which has extensive experience conducting clinical trials related to a wide range of therapeutic areas. The senior management team at WCCT has an average of 15+ years experience in CROs, large pharma and as clinical investigators. WCCT also has a world class Business Development team to meet the needs of sponsors.

WCCT has specific therapeutic expertise in Vaccines, Allergy, Asthma, Infectious Diseases, Pediatrics, Diabetes, Renal (including dialysis), Ophthalmology, and Heart Failure. WCCT has a unique focus on both NHV and special population ethnobridging studies including Japanese, Korean, Vietnamese, African American, Hispanic, and other ethnic population trials.

At WCCT we have extensive experience with healthy volunteer studies including First-in-Human (FIH) and all other types of standard PK and PK/PD studies including CSF sampling and various tissue biopsy studies. We also have extensive experience in special population, patient and ethnobridging studies.

In order optimize enrollment of early phase clinical trials in patient populations, WCCT can and has utilized a “Hybrid Model” approach. The major advantages for sponsors is the possibility of greatly accelerated timelines with minimal impact on overall study cost. This study design capitalizes on the best characteristics of traditional confined clinical and multi-center designs.

WCCT, through a network of trusted research partners, can provide clinical study conduct at additional CPUs as well as protocol writing, overall project management, monitoring, data management, biostatistics and medical writing.